Think you may have misinterpreted this one g. The article was merely talking about tb161 being a more promising radioisotope, compared to Lu177 which is used in Pluvicto and already on the market. RAD has a supply of tb161. It'll still need to be attached to our monoclonal antibodies have those studies done.
Think you may have misinterpreted this one g. The article was...
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.33M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.5¢ | 4.5¢ | $9.774K | 217.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 235179 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 137801 | 6 |
View Market Depth
| Last trade - 13.18pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
4.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 4.6¢ | 4.5¢ | 42129 | ||
| Last updated 14.04pm 30/04/2024 ? | |||||
| RAD (ASX) Chart |